|
Human phenolic hormones reveal their secrets
In this issue, we report progress on the three leading phenolic hormone compounds - NV-06, NV-04 and NV-07.
- NV-06 in human anti-cancer trials - NV-04 program achieves major milestone - NV-07 shows early promise as an anti-inflammatory compound - Rimostil prepares for market launch - Promensil delivers important health benefits in clinical studies - Novogen moves up in Nasdaq
<<< back
|
